Titan Company Limited has reported data regarding its debt securities issued through private placement, as per SEBI guidelines. The report, for the half-year ended September 30, 2025, details the status of listed, unsecured, redeemable, senior, non-cumulative, non-convertible debentures. It includes information on issuance dates, maturity dates, coupon rates, and outstanding amounts.

Debt Securities Report

Titan Company Limited has issued a report on its debt securities in compliance with SEBI regulations for the half-year ended September 30, 2025.

Details of Debt Securities

The report covers listed, unsecured, redeemable, senior, non-cumulative, non-convertible debentures issued through private placement.

Series 1 Debentures

These debentures (ISIN: INE280A08023) were issued on November 03, 2023, with a maturity date of May 05, 2025, and a coupon rate of 7.75%. The initially issued amount was Rs. 1,250 crore, but the outstanding amount is now Nil as they have been fully redeemed on May 05, 2025.

Series 2 Debentures

These debentures (ISIN: INE280A08015) were issued on November 03, 2023, with a maturity date of November 03, 2025, and a coupon rate of 7.75%. The issued amount is Rs. 1,250 crore, with an outstanding amount of Rs. 1,250 crore.

Source: BSE

Mankind Pharma has executed a Business Transfer Agreement to acquire the Branded Generic Business relating to Women Health Rx Portfolio from Bharat Serums & Vaccines Limited, a wholly-owned subsidiary. The acquisition consideration is ₹797 Crores, subject to closing adjustments. This strategic move expands Mankind Pharma’s product offerings in the women’s health segment. The acquisition is expected to close pending fulfillment of pre-conditions.

Portfolio Acquisition

Mankind Pharma has entered into an agreement to acquire a significant portfolio in the women’s health sector. The acquisition was formalized on October 10, 2025, through a Business Transfer Agreement (BTA) with Bharat Serums & Vaccines Limited (“BSV”). This acquisition strengthens Mankind Pharma’s position in the branded generic business.

Financial Details

The agreed-upon consideration for the acquisition of the Women Health Rx Portfolio is ₹797 Crores. This figure is subject to standard closing adjustments as outlined in the BTA. The consideration will be paid in two installments.

Payment Structure

The payment structure will be as follows:

• 50% of the sale consideration will be paid on the Closing Date.
• The balance of the sale consideration will be payable within 150 days from the Closing Date.

Closing Conditions

The completion of the acquisition is subject to standard pre-conditions. Closing actions and other terms and conditions are described in the BTA.

Source: BSE

L&T Finance has announced the allotment of Senior, Secured, Rated, Listed, Redeemable, Non-Convertible Debentures (NCDs) worth ₹10,500 crore through private placement. The NCDs have a face value of ₹1,00,000 each and were allotted to an identified investor on October 10, 2025. These debentures are proposed to be listed on the National Stock Exchange of India Limited.

NCD Allotment Details

L&T Finance has allotted Senior, Secured, Rated, Listed, Redeemable, Non-Convertible Debentures (NCDs) on a private placement basis. A total of 1,05,000 NCDs were allotted, with each debenture having a face value of ₹1,00,000. The total value of the NCDs allotted amounts to ₹10,500,00,00,000 (Rupees One Thousand and Fifty Crores Only).

Key Terms of the Debentures

The NCDs are Senior, Secured, Rated, and Listed, and are redeemable. The initial offering included 55,000 NCDs with an option to retain oversubscription up to 55,000 NCDs, allowing for a total issue size of up to ₹1100 crore. These NCDs were allotted to an identified investor on October 10, 2025, and are proposed to be listed on the New Debt Market segment of the National Stock Exchange of India Limited.

Tenor and Maturity

The original tenor of the debentures is 1127 days. The maturity date for the NCDs is November 10, 2028.

Coupon Rate and Payment Schedule

The coupon rate for these NCDs is set at 7.2190% p.a. The first coupon payment is scheduled for November 10, 2025, and subsequent payments will be made annually. Each debenture will receive annual coupon payouts of ₹7,219.0000, except for the initial short period coupon of ₹613.1205.

Principal Repayment

The principal amount of ₹1,00,000.0000 per NCD will be repaid on November 10, 2028, coinciding with the maturity date.

Security and Charge

The debentures are secured by an exclusive and first-ranking charge via hypothecation on identified fixed deposits and/or standard receivables of L&T Finance. The value of these hypothecated assets will be equivalent to 1 time the principal amount and any outstanding coupon payments.

Redemption Details

The NCDs will be redeemed at a price of ₹1,00,000 per NCD on the maturity date.

Source: BSE

Akums Drugs & Pharmaceuticals Limited has announced the resignation of Mr. Sanjay Sharma, President – Portfolio & Strategy, effective October 10, 2025. Mr. Sharma’s last working day was October 10, 2025, with his resignation tendered on August 13, 2025. The company has accepted his resignation and relieved him from his duties.

Senior Management Change

Mr. Sanjay Sharma, President – Portfolio & Strategy at Akums Drugs & Pharmaceuticals Limited, has resigned from his position. His resignation was effective October 10, 2025.

Reason for Departure

Mr. Sharma’s resignation was submitted on August 13, 2025. His last working day with the company was October 10, 2025. The company cited personal reasons related to a family medical emergency as the primary driver for his decision.

Company Response

Akums Drugs has accepted Mr. Sharma’s resignation and relieved him of his responsibilities from October 10, 2025. The company acknowledged his contributions and support during his tenure.

Source: BSE

Nestlé India has announced a series of senior management changes effective January 1, 2026, pending necessary approvals. Key shifts include leadership changes in Nutrition, Dairy, Confectionery, and Cereals. The company is reorganizing roles in Corporate Affairs, Supply Chain, and Legal & Compliance to streamline operations and enhance strategic focus. These changes aim to support Nestlé India’s growth and market position.

Leadership Changes Across Key Divisions

Nestlé India is set to implement a significant internal reorganization impacting several key senior management roles, beginning January 1, 2026. This strategic restructuring will affect the leadership of various business units and corporate functions.

Key Management Appointments

Mr. Vineet Singh, currently BEO – Nutrition, will now lead the combined Nutrition and Dairy portfolio. Consequently, Mr. Manav Sahni, BEO – Dairy, will transition to a new role within Nestlé.

Mr. Gopichandar Jagatheesan, presently BEO – Confectionery, will oversee the combined Confectionery and Cereals portfolio. Mr. Varun Sethuraman, currently BEO – Cereals, will move to the role of Head – Marketing Communications. As a result, Mr. Chandan Mukherji will step down as Head – Strategy and Marketing Communications.

Expanded Responsibilities and Departures

Mr. Varun Gupta, Head – Supply Chain, will additionally oversee Exports & Imports Business. Consequently, Mr. Vasudevan Krishnan will be stepping down as Head – Exports & Imports Business.

Mr. Himmat Singh, Head – Corporate Affairs, will lead a combined portfolio of Corporate Affairs, Sustainability & Societal Initiatives. As a result, Ms. Taruna Saxena will step down as Head – Sustainability and Societal Initiatives.

Ms. Dhwani Rao, currently Associate General Counsel, will assume the role of General Counsel and Head – Legal & Compliance. Consequently, Mr. T S Venkateswaran will step down as the General Counsel and Head – Legal & Compliance.

Source: BSE

Varun Beverages Limited announced a change in its senior management. Mr. Rohit Vishal Gupta, previously Chief Human Resources Officer, has been relieved from his duties, effective October 10, 2025. This leadership transition is part of the company’s ongoing organizational adjustments, and the company has initiated the process to ensure a seamless handover of responsibilities.

Senior Management Update

Varun Beverages Limited confirms the departure of Mr. Rohit Vishal Gupta from the position of Chief Human Resources Officer. His last working day was October 10, 2025. The company acknowledges his contributions during his tenure.

Effective Date of Transition

The leadership change is effective as of October 10, 2025. Varun Beverages is managing the transition to maintain operational continuity.

Source: BSE

Patanjali Foods confirms the dematerialization of securities for the quarter ended September 30, 2025. The details, as required under Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, have been furnished to the stock exchanges where the company’s shares are listed. Confirmation has also been received from Sarthak Global Limited, the Registrar and Transfer Agent.

Dematerialization Confirmation

Patanjali Foods has successfully completed the dematerialization of its securities for the second quarter of FY26, ending September 30, 2025. This announcement confirms compliance with regulatory requirements concerning depositories and participants.

Regulatory Compliance

The company has formally certified that all details regarding the dematerialized securities have been duly provided to the respective stock exchanges. This adheres to the stipulations outlined in the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

RTA Confirmation

Sarthak Global Limited, the Registrar and Transfer Agent (RTA), has provided a letter confirming the completion of the dematerialization process. They confirmed that securities received for dematerialization during the quarter ended September 30, 2025, were processed within 15 days.

Security Certificate Handling

Sarthak Global Limited further affirmed that all security certificates received for dematerialization have been mutilated and canceled following verification. The register of members has been updated to reflect the changes in ownership, ensuring full compliance with regulatory guidelines.

Source: BSE

Inventurus Knowledge Solutions has received the confirmation certificate regarding dematerialization of securities for the quarter ended September 30, 2025. The certificate, received from MUFG Intime India Private Limited, confirms compliance with regulatory requirements and ensures that all securities transactions are duly processed and verified. This announcement reaffirms the company’s commitment to maintaining transparency and adherence to established protocols.

Certificate of Confirmation

Inventurus Knowledge Solutions has announced the receipt of a certificate from MUFG Intime India Private Limited concerning the handling of securities during Q2 FY26 (quarter ended September 30, 2025).

Details of Compliance

The certificate confirms that all securities received for dematerialization during the specified quarter have been duly processed. This includes verification and confirmation to the depositories, ensuring that the securities are listed on the stock exchanges. The process also includes mutilation and cancellation of security certificates after verification by the depository participant. Names of the depositories have been accurately substituted in the register of members, aligning with regulatory timelines.

Source: BSE

Elecon Engineering Company Limited reported a 14% year-over-year increase in revenue to ₹578 crores for Q2FY26. EBITDA rose by 12% to ₹126 crores. The company’s order intake stood strong at ₹688 crores, a 28% increase YoY. Elecon is on track to reach ₹2,650 crores revenue for FY26, supported by healthy demand in domestic and overseas markets.

Financial Performance

For Q2FY26, Elecon reported consolidated revenue of ₹578 crores, up 13.8% year-over-year. EBITDA for the quarter was ₹126 crores, with a margin of 21.7%. Profit after tax (PAT) reached ₹88 crores, a 15.2% margin. Order intake for the quarter reached ₹688 crores, a 28% YoY increase.

H1FY26 Highlights

Consolidated revenue for H1FY26 was ₹1,069 crores, reflecting a 19% increase year-over-year. This includes ₹25 crores of one-time income from an arbitration claim settlement within the Material Handling Equipment (MHE) division. EBITDA for H1FY26 reached ₹256 crores, a 25% increase year-over-year.

Segment Performance

The Material Handling Equipment (MHE) division experienced strong growth, with a 33.0% year-over-year revenue increase in Q2FY26. The Gears division demonstrated resilience, with an 8.9% YoY revenue growth. Elecon is targeting 50% of consolidated revenue from international markets by FY30.

Order Book

As of September 30, 2025, the company’s open order stood at ₹1,226 crores compared to ₹966 crores as of September 30, 2024. Order intake for the Gear division in Q2FY26 was ₹497 Crs. The MHE division reported order intake of ₹191 Crs for Q2FY26, compared to the ₹104 Crs in Q2FY25, showing an 84% year-over-year growth.

Values & Safety

The company maintains zero accidents in H1FY26 and has safety audits, mock drills and comprehensive training programs in place. Elecon values include Delightful Customer Experience, Resolute Trust, Ingenious Entrepreneurship, Value Creation, and Ethics at the Core. A focus on learning, wealth and research are part of their value creation ethics.

Environmental Initiatives

The company is committed to reducing emissions, using renewable energy and conserving resources. They plan to reduce absolute scope 1 and 2 GHG emissions by 54.6% by FY33 from a FY23 base year.

Source: BSE

Patanjali Foods clarifies its earlier announcement regarding the intention of resignation by M/s. Chaturvedi & Shah LLP as Statutory Auditors. The company states that while the auditors have conveyed their intention to resign, a formal resignation has not yet been received. Once the formal resignation is received, the company will provide all required details.

Clarification on Auditor Status

Patanjali Foods has addressed concerns regarding the potential resignation of its Statutory Auditors, M/s. Chaturvedi & Shah LLP. The company confirms that, as of October 10, 2025, a formal resignation letter has not been submitted by the auditors. The announcement serves to clarify the current status and address any ambiguities arising from the initial communication.

Intention vs. Formal Resignation

While M/s. Chaturvedi & Shah LLP have communicated their intention to resign as Statutory Auditors, the company emphasizes that this intention has not yet materialized into a formal resignation. The initial announcement, dated October 09, 2025, prompted inquiries regarding the details surrounding the auditor’s departure.

Commitment to Disclosure

Patanjali Foods assures stakeholders that upon receiving the formal resignation from M/s. Chaturvedi & Shah LLP, it will promptly disclose all requisite information. The company is committed to adhering to all regulatory requirements and ensuring transparency in its communications with the Stock Exchange. The company will share the required details and adhere to prescribed timelines once the formal resignation process is initiated.

Source: BSE